Update on benefit of immunotherapy and targeted therapy in melanoma: the changing landscape

por Srivastava, Neeharika, McDermott, David
Publicado 2014

PD-1 as a potential target in cancer therapy

por McDermott, David F, Atkins, Michael B
Publicado 2013

Management of metastatic renal cell carcinoma in patients with poor prognosis

por Bullock, Andrea, McDermott, David F, Atkins, Michael B
Publicado 2010

Enhancing Antitumor Immunity with Antiangiogenic Therapy: A Clinical Model in Renal Cell Carcinoma?

por Gao, Xin, McDermott, David F., Michaelson, M. Dror
Publicado 2019

Chromothriptic cure of WHIM syndrome: Implications for bone marrow transplantation

por McDermott, David H, Gao, Ji-Liang, Murphy, Philip M
Publicado 2015

Predictors of Pathologic Response After Total Neoadjuvant Therapy in Patients With Rectal Adenocarcinoma: A National Cancer Database Analysis

por McDermott, David M, Singh, Sarah A, Renz, Paul B, Hasan, Shaakir, Weir, Josh
Publicado 2021

The effect of Rho kinase inhibition on long-term keratinocyte proliferation is rapid and conditional

por Chapman, Sandra, McDermott, David H, Shen, Kui, Jang, Moon Kyoo, McBride, Alison A
Publicado 2014

Radiographic and Tumor Biomarker Response to Radiotherapy for Recurrent Granulosa Cell Tumor of the Ovary

por Singh, Sarah A, Dahshan, Basem, Krc, Rebecca F, McDermott, David M, Jacobson, Geraldine M
Publicado 2021

Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2

por Kaufman, Howard L, Aung, Sandra, Morse, Michael, Wong, Michael, Lowder, James, Daniels, Gregory, McDermott, David
Publicado 2014

LITESPARK-024: A randomized phase 1/2 study of belzutifan with or without palbociclib for previously treated advanced renal cell carcinoma

por McDermott, David F, Peer, Avivit, Agarwal, Neeraj, Atkins, Michael B, Cornell, Jerry, Perini, Rodolfo F, Grossmann, Kenneth F, Gurney, Howard
Publicado 2023

FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer

por Chen, James L, Appelbaum, Daniel E, Kocherginsky, Masha, Cowey, Charles L, Kimryn Rathmell, Wendy, McDermott, David F, Stadler, Walter M
Publicado 2013

High dose interleukin-2 registry, PROCLAIM™; higher center-specific IL-2 dose density correlates with higher response rates

por Wong, Michael K, Daniels, Gregory A, Kaufman, Howard L, McDermott, David F, Morse, Michael A, Aung, Sandra, Lowder, James N
Publicado 2013

Implementation of an Interleukin-2 National Registry: an opportunity to improve cancer outcomes

por Wong, Michael K, Kaufman, Howard L, Daniels, Gregory A, McDermott, David F, Aung, Sandra, Lowder, James N, Morse, Michael A
Publicado 2014

The Use of Registries to Improve Cancer Treatment: A National Database for Patients Treated with Interleukin-2 (IL-2)

por Kaufman, Howard L., Wong, Michael K., Daniels, Gregory A., McDermott, David F., Aung, Sandra, Lowder, James N., Morse, Michael A.
Publicado 2014

Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors

por Mantia, Charlene M., Werner, Lillian, Stwalley, Brian, Ritchings, Corey, Tarhini, Ahmad A., Atkins, Michael B., McDermott, David F., Regan, Meredith M.
Publicado 2021

Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review

por Schoenfeld, Jonathan D., Mahadevan, Anand, Floyd, Scott R., Dyer, Michael A., Catalano, Paul J., Alexander, Brian M., McDermott, David F., Kaplan, Irving D.
Publicado 2015

Tivozanib in Patients with Advanced Renal Cell Carcinoma Previously Treated with Axitinib: Subgroup Analysis from TIVO-3

por Meza, Luis, McDermott, David F, Escudier, Bernard, Hutson, Thomas E, Porta, Camillo, Verzoni, Elena, Atkins, Michael B, Kasturi, Vijay, Pal, Sumanta K, Rini, Brian
Publicado 2022

Phase Ib dose-finding study of axitinib plus pembrolizumab in treatment-naïve patients with advanced renal cell carcinoma

por Atkins, Michael B, Gupta, Shilpa, Choueiri, Toni K, McDermott, David F, Puzanov, Igor, Tarazi, Jamal, Keefe, Stephen, Rosbrook, Brad, Chakrabarti, Debasis, Plimack, Elizabeth R
Publicado 2015

CCR5 deficiency increases risk of symptomatic West Nile virus infection

por Glass, William G., McDermott, David H., Lim, Jean K., Lekhong, Sudkamon, Yu, Shuk Fong, Frank, William A., Pape, John, Cheshier, Ronald C., Murphy, Philip M.
Publicado 2006

Overall survival of metastatic melanoma patients treated with HD IL-2 followed by immune checkpoint blockade of the CTLA-4 or the PD-1 pathways: analysis of data on the current use...

por Wong, Michael KK, Morse, Michael A, McDermott, David F, Clark, Joseph I, Kaufman, Howard L, Daniels, Gregory A, Perritt, Jessica C, Hua, Hong, Aung, Sandra
Publicado 2015